Munich, Germany

Volker Fachinger

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2004.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Volker Fachinger

Introduction

Volker Fachinger is a notable inventor based in Munich, Germany. He has made significant contributions to the field of chemistry, particularly in the preparation and purification of complex compounds. His work is characterized by a commitment to advancing industrial processes.

Latest Patents

Fachinger holds a patent for a process titled "Process for preparing and purifying 1,7′-dimethyl-2′-propyl-2,5′-bi-1H-benzimidazole." This innovative process allows for the industrial-scale preparation and purification of this compound, utilizing charcoal treatment to enhance the quality of the final product. His patent represents a valuable advancement in chemical manufacturing.

Career Highlights

Volker Fachinger is associated with Boehringer Ingelheim Pharma GmbH & Co. KG, a leading global pharmaceutical company. His role at the company has allowed him to apply his expertise in chemistry to develop processes that improve product quality and efficiency. Fachinger's dedication to innovation has made him a respected figure in his field.

Collaborations

Fachinger has worked alongside esteemed colleagues such as Hartmut Schmidt and Werner Belzer. Their collaborative efforts have contributed to the success of various projects within the pharmaceutical industry.

Conclusion

Volker Fachinger's contributions to the field of chemistry and his innovative patent demonstrate his commitment to advancing industrial processes. His work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…